
"Sector" = median of Healthcare across 86 companies
Roche Holding Ltd (RHHBF) closed at 415.00 USD, down 0.48% in the past 24 hours. The decline aligns with broader sector concerns as a recent article highlighted Merck's Keytruda facing a patent cliff, potentially shifting focus to new cancer drugs. Roche's oncology portfolio may be impacted by competitive dynamics, though no company-specific news drove the move. The stock remains under pressure amid ongoing patent expiry discussions in the industry.
Latest saved period: December 2025 · 2025-12-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 13, 2026 | $12.76 | Mar 16, 2026 | Annual |
| Mar 12, 2026 | $1.28 | Mar 16, 2026 | None |
| Mar 28, 2025 | $11.01 | Mar 31, 2025 | Annual |
| Mar 14, 2024 | $10.93 | Mar 18, 2024 | Annual |
| Mar 16, 2023 | $10.18 | Mar 20, 2023 | Annual |
| Mar 17, 2022 | $9.89 | Mar 21, 2022 | Annual |
| Mar 18, 2021 | $9.87 | Mar 22, 2021 | Annual |
| Mar 19, 2020 | $9.30 | Mar 23, 2020 | Annual |
| Mar 7, 2019 | $8.66 | Mar 11, 2019 | Annual |
| Mar 15, 2018 | $8.78 | Mar 19, 2018 | Annual |
| Mar 16, 2017 | $8.20 | Mar 20, 2017 | Annual |
| Mar 3, 2016 | $8.13 | Mar 7, 2016 | Annual |
| Mar 5, 2015 | $8.31 | Mar 10, 2015 | Annual |
| Mar 6, 2014 | $8.79 | Mar 11, 2014 | Annual |
| Mar 7, 2013 | $7.35 | Mar 12, 2013 | Annual |
| Mar 8, 2012 | $7.49 | Mar 13, 2012 | Annual |
| Mar 3, 2011 | $7.09 | Mar 8, 2011 | Annual |
| Mar 4, 2010 | $5.58 | Mar 9, 2010 | Annual |
| Mar 16, 2009 | $4.22 | Mar 16, 2009 | Annual |
| Mar 7, 2008 | $4.49 | Mar 7, 2008 | Annual |
| Mar 8, 2007 | $2.78 | Mar 8, 2007 | Annual |
| Mar 2, 2006 | $1.91 | Mar 2, 2006 | Annual |
| Mar 3, 2005 | $2.00 | Mar 3, 2005 | Annual |
| Apr 13, 2004 | $1.65 | Apr 13, 2004 | Annual |
Wrqti brings Roche Holding Ltd data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Roche Holding Ltd:
Compare Roche Holding Ltd head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: December 2025.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.